Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | KMO | O15229 | 1/20 | 0.54 |
| ▸ | DAO | P14920 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 4/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29487730 | 0.85 | RECQL (0.46) | RECQLCYP1A2KMODAOPOLB | |
| SCHEMBL5565705 | 0.84 | CYP1A2 (0.62) | RECQLCYP1A2KMODAOPOLB | |
| SCHEMBL29487638 | 0.84 | CYP1A2 (0.62) | RECQLCYP1A2KMODAOPOLB | |
| SCHEMBL1326630 | 0.81 | CYP1A2 (0.58) | RECQLCYP1A2KMODAOPOLB | |
| SCHEMBL7331551 | 0.81 | RECQL (0.69) | RECQLCYP1A2KMODAOPOLB | |
| SCHEMBL7332016 | 0.80 | RECQL (0.53) | RECQLCYP1A2KMODAOPOLB | |
| SCHEMBL861732 | 0.80 | CYP1A2 (0.57) | RECQLCYP1A2KMODAOPOLB | |
| SCHEMBL9934408 | 0.79 | RECQL (0.61) | RECQLCYP1A2KMODAOPOLB | |
| SCHEMBL29520910 | 0.79 | RECQL (0.61) | RECQLCYP1A2KMODAOPOLB | |
| SCHEMBL29520779 | 0.79 | RECQL (0.61) | RECQLCYP1A2KMODAOPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024193328-A1 | INDAZOLE SUBSTITUTED PODOPHYLLOTOXIN DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 汤亚杰 | 2024-09-26 | — | — | WO | claimed |
| US-20230052747-A1 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF TUMORS | TES PHARMA S.R.L. (IT) | 2023-02-16 | — | — | US | claimed |
| EP-1255797-B2 | METHOD FOR ROUGHENING COPPER SURFACES FOR BONDING TO SUBSTRATES | OMG ELECTRONIC CHEMICALS INC (US) | 2016-10-12 | — | — | EP | claimed |
| EP-1255797-B1 | METHOD FOR ROUGHENING COPPER SURFACES FOR BONDING TO SUBSTRATES | OMG ELECTRONIC CHEMICALS INC (US) | 2012-06-13 | — | — | EP | claimed |
| EP-2419551-A2 | ELECTROLYTE AND SURFACE-ACTIVE ADDITIVES FOR THE GALVANIC DEPOSITION OF SMOOTH, DENSE ALUMINUM LAYERS FROM IONIC LIQUIDS | BASF SE (DE) | 2012-02-22 | — | — | EP | claimed |
| US-20120006688-A1 | ELECTROLYTE AND SURFACE-ACTIVE ADDITIVES FOR THE ELECTROCHEMICAL DEPOSITION OF SMOOTH, DENSE ALUMINUM LAYERS FROM IONIC LIQUIDS | BASF SE (DE) | 2012-01-12 | — | — | US | claimed |
| JP-4754752-B2 | — | — | 2011-08-24 | — | — | JP | claimed |
| WO-2010106072-A2 | ELECTROLYTE AND SURFACE-ACTIVE ADDITIVES FOR THE GALVANIC DEPOSITION OF SMOOTH, DENSE ALUMINUM LAYERS FROM IONIC LIQUIDS | BASF SE (DE) | 2010-09-23 | — | — | WO | claimed |
| EP-1255797-A4 | METHOD FOR ROUGHENING COPPER SURFACES FOR BONDING TO SUBSTRATES | ELECTROCHEMICALS INC (US) | 2009-01-14 | — | — | EP | claimed |
| CN-100340632-C | Method for roughening copper surfaces for bonding to substrates | ELECTROCHEMICALS INC (US) | 2007-10-03 | — | — | CN | claimed |
| CN-1451031-A | Method for roughening copper surfaces for bonding to substrates | ELECTROCHEMICALS INC (US) | 2003-10-22 | — | — | CN | claimed |
| JP-2003519286-A | — | — | 2003-06-17 | — | — | JP | claimed |
| EP-1255797-A1 | METHOD FOR ROUGHENING COPPER SURFACES FOR BONDING TO SUBSTRATES | ELECTROCHEMICALS INC. (US) | 2002-11-13 | — | — | EP | claimed |
| WO-2001049805-A1 | METHOD FOR ROUGHENING COPPER SURFACES FOR BONDING TO SUBSTRATES | ELECTROCHEMICALS INC. (US) | 2001-07-12 | — | — | WO | claimed |
| US-5543517-A | VIRICIDES | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-08-06 | — | — | US | claimed |
| US-20260055062-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | Vettore, LLC | 2026-02-26 | — | — | US | disclosed |
| US-12492171-B2 | Heterocyclic inhibitors of MCT4 | Vettore, LLC (US) | 2025-12-09 | — | — | US | disclosed |
| EP-1255797-A1 | METHOD FOR ROUGHENING COPPER SURFACES FOR BONDING TO SUBSTRATES | ELECTROCHEMICALS INC. (US) | 2002-11-13 | — | — | EP | disclosed |
| US-20020084441-A1 | Method for roughening copper surfaces for bonding to substrates | MACDERMID, INCORPORATED | 2002-07-04 | — | — | US | disclosed |
| WO-2001049805-A1 | METHOD FOR ROUGHENING COPPER SURFACES FOR BONDING TO SUBSTRATES | ELECTROCHEMICALS INC. (US) | 2001-07-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12492171-B2 | Heterocyclic inhibitors of MCT4 | SLC16A3, SLC16A1, MCTS1 | RECQL 2496/4885CYP1A2 2974/4885KMO 1510/4885 |
| US-20230052747-A1 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF TUMORS | RAD51, BRCA1, FANCI | RECQL 29/4885CYP1A2 1815/4885KMO 3566/4885 |
| US-20260055062-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | SLC16A1, SLC16A3, SLC16A7 | RECQL 3317/4885CYP1A2 2037/4885KMO 1040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.